Jeff Lagasse
A new report released today by healthcare nonprofit The Leapfrog Group, and analyzed by Castlight Health, said that only 47 percent of hospitals reporting in the 2015 Leapfrog Hospital Survey have the recommended coverage in place regarding intensivists -- highly specialized physicians who work in intensive care units.
New estimates from the Centers for Medicare and Medicaid Services project that health spending growth will outpace the expected average growth in gross domestic product for almost the entire next decade.
GE Healthcare has acquired Biosafe Group, which supplies integrated cell bioprocessing systems for the cell therapy and regenerative medicine industry, for an undisclosed sum, the company announced Wednesday.
Evolent Health, which helps healthcare systems make the transition to value-based care, will acquire the majority of Valence Health's business for about $145 million, the company announced Wednesday.
Even when patients were grouped by characteristics such as age or severity of illness, hospitals differed significantly in inpatient costs, length of stay, and time spent in the intensive care unit.
Health Central Hospital in Ocoee, Florida will open the first phase of a newly reconstructed emergency department this month, the renovation of the current emergency department space, and new patient tower.
HealthSouth Corporation is planning a physical rehabilitation hospital in Alabama's Shelby County, the health system announced Monday. Financial terms of the project were not disclosed.
High-need individuals who cost the public or private sectors $50,000 or more in a single year top the list of the most expensive sources of healthcare costs, according to a study released by the American Health Policy Institute.
Integrated healthcare delivery and financing company UPMC is taking steps to thwart wasteful spending and high costs in forming an independent company called Pensiamo, which aims to help hospitals improve supply chain performance with a source-to-pay offering, including cognitive analytics with IBM Watson Health Technologies.
The Centers for Medicare and Medicaid Services announced Thursday that it has barred Theranos founder and CEO Elizabeth Holmes from the blood-testing business for two years, according to a statement on the company's website.